Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Choy, Ernest, Caporali, Roberto, Xavier, Ricardo, Fautrel, Bruno, Sanmarti, Raimón, Bao, Min, Bernasconi, Corrado, Pethö-Schramm, Attila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Errata
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5965097/
https://www.ncbi.nlm.nih.gov/pubmed/29635639
http://dx.doi.org/10.1093/rheumatology/key116
_version_ 1783325292300861440
author Choy, Ernest
Caporali, Roberto
Xavier, Ricardo
Fautrel, Bruno
Sanmarti, Raimón
Bao, Min
Bernasconi, Corrado
Pethö-Schramm, Attila
author_facet Choy, Ernest
Caporali, Roberto
Xavier, Ricardo
Fautrel, Bruno
Sanmarti, Raimón
Bao, Min
Bernasconi, Corrado
Pethö-Schramm, Attila
author_sort Choy, Ernest
collection PubMed
description
format Online
Article
Text
id pubmed-5965097
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-59650972018-06-04 Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries Choy, Ernest Caporali, Roberto Xavier, Ricardo Fautrel, Bruno Sanmarti, Raimón Bao, Min Bernasconi, Corrado Pethö-Schramm, Attila Rheumatology (Oxford) Errata Oxford University Press 2018-06 2018-04-06 /pmc/articles/PMC5965097/ /pubmed/29635639 http://dx.doi.org/10.1093/rheumatology/key116 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Errata
Choy, Ernest
Caporali, Roberto
Xavier, Ricardo
Fautrel, Bruno
Sanmarti, Raimón
Bao, Min
Bernasconi, Corrado
Pethö-Schramm, Attila
Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries
title Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries
title_full Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries
title_fullStr Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries
title_full_unstemmed Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries
title_short Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries
title_sort subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme tozura conducted in 22 countries
topic Errata
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5965097/
https://www.ncbi.nlm.nih.gov/pubmed/29635639
http://dx.doi.org/10.1093/rheumatology/key116
work_keys_str_mv AT choyernest subcutaneoustocilizumabinrheumatoidarthritisfindingsfromthecommonframeworkphase4studyprogrammetozuraconductedin22countries
AT caporaliroberto subcutaneoustocilizumabinrheumatoidarthritisfindingsfromthecommonframeworkphase4studyprogrammetozuraconductedin22countries
AT xavierricardo subcutaneoustocilizumabinrheumatoidarthritisfindingsfromthecommonframeworkphase4studyprogrammetozuraconductedin22countries
AT fautrelbruno subcutaneoustocilizumabinrheumatoidarthritisfindingsfromthecommonframeworkphase4studyprogrammetozuraconductedin22countries
AT sanmartiraimon subcutaneoustocilizumabinrheumatoidarthritisfindingsfromthecommonframeworkphase4studyprogrammetozuraconductedin22countries
AT baomin subcutaneoustocilizumabinrheumatoidarthritisfindingsfromthecommonframeworkphase4studyprogrammetozuraconductedin22countries
AT bernasconicorrado subcutaneoustocilizumabinrheumatoidarthritisfindingsfromthecommonframeworkphase4studyprogrammetozuraconductedin22countries
AT pethoschrammattila subcutaneoustocilizumabinrheumatoidarthritisfindingsfromthecommonframeworkphase4studyprogrammetozuraconductedin22countries

Ejemplares similares